This trial is testing a new cancer treatment combination for safety and effectiveness in people with pancreatic cancer that has spread.
1 Primary · 2 Secondary · Reporting Duration: 4 years
Experimental Treatment
21 Total Participants · 1 Treatment Group
Primary Treatment: Plerixafor · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: